Chemoprevention of colorectal cancer with cyclooxygenase-2 inhibitors: two steps forward, one step back

This publication has 15 references indexed in Scilit:

• Celecoxib for the Prevention of Sporadic Colorectal Adenomas
  New England Journal of Medicine, 2006
• PROSTAGLANDINS AND CANCER
  Gut, 2006
• Prostaglandins promote colon cancer cell invasion; signaling by cross‐talk between two distinct growth factor receptors
  The FASEB Journal, 2003
• Therapeutic Potential of Selective Cyclooxygenase-2 Inhibitors in the Management of Tumor Angiogenesis
  Published by S. Karger AG ,2003
• The Role of Cyclooxygenase Inhibitors in Cancer Prevention
  Current Pharmaceutical Design, 2002
• Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy
  Nature Medicine, 2002
• The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
  New England Journal of Medicine, 2000
• Cyclooxygenase 2 inhibitors: discovery, selectivity and the future
  Trends in Pharmacological Sciences, 1999
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)
  Cell, 1996
• A Case–Control Study of Screening Sigmoidoscopy and Mortality from Colorectal Cancer
  New England Journal of Medicine, 1992